Pekin Hardy Strauss’s Iovance Biotherapeutics IOVA Stock Holding History

Pekin Hardy Strauss’s Portfolio IOVA Stock Details IOVA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-11,050	Closed	-$19K	–	421
2025 Q2	$19K	Sell	11,050 -17,000	-61%	-$42.3K	﹤0.01%	360
2025 Q1	$93.4K	Hold	28,050	–	–	0.01%	348
2024 Q4	$208K	Sell	28,050 -5,000	-15%	-$46.3K	0.03%	331
2024 Q3	$310K	Sell	33,050 -2,000	-6%	-$18.9K	0.04%	287
2024 Q2	$281K	Sell	35,050 -8,000	-19%	-$85.7K	0.04%	267
2024 Q1	$638K	Sell	43,050 -9,950	-19%	-$116K	0.09%	193
2023 Q4	$431K	Sell	53,000 -3,000	-5%	-$15.7K	0.06%	210
2023 Q3	$255K	Buy	+56,000	New	+$366K	0.04%	249

Other funds holding IOVA

MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Invenomic Capital Management Boston, Massachusetts $2.18B AUM 0.03% 1-Year Est. Return

Long Focus Capital Management San Juan, Puerto Rico $3.8B AUM 7.31% 1-Year Est. Return

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Bank of America

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return